Cargando…

STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells

SIMPLE SUMMARY: Prostate cancer (PCa) is the most common non-skin cancer and one of the leading causes of cancer death in men. Despite significant developments in therapy options with improved survival, no curative treatment is currently available. We have previously identified six transmembrane pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Pihlstrøm, Nicklas, Jin, Yang, Nenseth, Zeynep, Kuzu, Omer F., Saatcioglu, Fahri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036285/
https://www.ncbi.nlm.nih.gov/pubmed/33808059
http://dx.doi.org/10.3390/cancers13071579
_version_ 1783676874342268928
author Pihlstrøm, Nicklas
Jin, Yang
Nenseth, Zeynep
Kuzu, Omer F.
Saatcioglu, Fahri
author_facet Pihlstrøm, Nicklas
Jin, Yang
Nenseth, Zeynep
Kuzu, Omer F.
Saatcioglu, Fahri
author_sort Pihlstrøm, Nicklas
collection PubMed
description SIMPLE SUMMARY: Prostate cancer (PCa) is the most common non-skin cancer and one of the leading causes of cancer death in men. Despite significant developments in therapy options with improved survival, no curative treatment is currently available. We have previously identified six transmembrane protein of prostate 2 (STAMP2) as an important factor for PCa growth and survival. We now show that STAMP2 expression is regulated by inflammatory signaling, which has recently been implicated in PCa. Two proinflammatory cytokines, interleukin 6 and interleukin 1 beta, synergize with each other to induce STAMP2 expression. Interestingly, STAMP2 knockdown increased the sensitivity of PCa cells to cytokine treatment. Thus, STAMP2 that acts as a survival factor in PCa, is both independently and synergistically regulated by inflammatory signaling that may affect disease progression. ABSTRACT: Inflammatory events and dysregulated cytokine expression are implicated in prostate cancer (PCa), but the underlying molecular mechanisms are poorly understood at present. We have previously identified six transmembrane protein of the prostate 2 (STAMP2, also known as STEAP4) as an androgen-regulated gene, as well as a key regulator of PCa growth and survival. STAMP2 is also regulated by, and participates in, inflammatory signaling in other tissues and pathologies. Here, we show that the proinflammatory cytokines interleukin 6 (IL-6) and Interleukin 1 beta (IL-1β) significantly increase and strongly synergize in promoting STAMP2 expression in PCa cells. The two cytokines increase androgen-induced STAMP2 expression, but not expression of other known androgen target genes, suggesting a unique interplay of androgens and cytokines in regulating STAMP2 expression. Interestingly, STAMP2 knockdown significantly increased the ability of IL-6 and IL-1β to inhibit PCa cell growth in vitro. These results suggest that STAMP2 may represent a unique node through which inflammatory events mediate their effects on PCa growth and survival.
format Online
Article
Text
id pubmed-8036285
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80362852021-04-12 STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells Pihlstrøm, Nicklas Jin, Yang Nenseth, Zeynep Kuzu, Omer F. Saatcioglu, Fahri Cancers (Basel) Article SIMPLE SUMMARY: Prostate cancer (PCa) is the most common non-skin cancer and one of the leading causes of cancer death in men. Despite significant developments in therapy options with improved survival, no curative treatment is currently available. We have previously identified six transmembrane protein of prostate 2 (STAMP2) as an important factor for PCa growth and survival. We now show that STAMP2 expression is regulated by inflammatory signaling, which has recently been implicated in PCa. Two proinflammatory cytokines, interleukin 6 and interleukin 1 beta, synergize with each other to induce STAMP2 expression. Interestingly, STAMP2 knockdown increased the sensitivity of PCa cells to cytokine treatment. Thus, STAMP2 that acts as a survival factor in PCa, is both independently and synergistically regulated by inflammatory signaling that may affect disease progression. ABSTRACT: Inflammatory events and dysregulated cytokine expression are implicated in prostate cancer (PCa), but the underlying molecular mechanisms are poorly understood at present. We have previously identified six transmembrane protein of the prostate 2 (STAMP2, also known as STEAP4) as an androgen-regulated gene, as well as a key regulator of PCa growth and survival. STAMP2 is also regulated by, and participates in, inflammatory signaling in other tissues and pathologies. Here, we show that the proinflammatory cytokines interleukin 6 (IL-6) and Interleukin 1 beta (IL-1β) significantly increase and strongly synergize in promoting STAMP2 expression in PCa cells. The two cytokines increase androgen-induced STAMP2 expression, but not expression of other known androgen target genes, suggesting a unique interplay of androgens and cytokines in regulating STAMP2 expression. Interestingly, STAMP2 knockdown significantly increased the ability of IL-6 and IL-1β to inhibit PCa cell growth in vitro. These results suggest that STAMP2 may represent a unique node through which inflammatory events mediate their effects on PCa growth and survival. MDPI 2021-03-30 /pmc/articles/PMC8036285/ /pubmed/33808059 http://dx.doi.org/10.3390/cancers13071579 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Pihlstrøm, Nicklas
Jin, Yang
Nenseth, Zeynep
Kuzu, Omer F.
Saatcioglu, Fahri
STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells
title STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells
title_full STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells
title_fullStr STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells
title_full_unstemmed STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells
title_short STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells
title_sort stamp2 expression mediated by cytokines attenuates their growth-limiting effects in prostate cancer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036285/
https://www.ncbi.nlm.nih.gov/pubmed/33808059
http://dx.doi.org/10.3390/cancers13071579
work_keys_str_mv AT pihlstrømnicklas stamp2expressionmediatedbycytokinesattenuatestheirgrowthlimitingeffectsinprostatecancercells
AT jinyang stamp2expressionmediatedbycytokinesattenuatestheirgrowthlimitingeffectsinprostatecancercells
AT nensethzeynep stamp2expressionmediatedbycytokinesattenuatestheirgrowthlimitingeffectsinprostatecancercells
AT kuzuomerf stamp2expressionmediatedbycytokinesattenuatestheirgrowthlimitingeffectsinprostatecancercells
AT saatcioglufahri stamp2expressionmediatedbycytokinesattenuatestheirgrowthlimitingeffectsinprostatecancercells